MTIP Invests $15 Million in Caresyntax
MTIP invested $15 million to accelerate Caresyntax's commercial growth and to expand its data-driven surgery platform.
MTIP invested $15 million to accelerate Caresyntax's commercial growth and to expand its data-driven surgery platform.
● The Fund’s focus is on healthcare innovations that improve patient outcomes
● Leveraging Earlybird Eagle Eye, a cutting-edge proprietary AI tool, the Fund
gains deal flow and market intelligence
● Uniquely, the only European fund with public…
FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications
Special receptor cells under the skin enable us to feel pain and touch. But Schwann cells also play a key role in detecting such stimuli, researchers at the Max Delbrück Center report in “Nature Communications.” This discovery opens new avenues for…
A new computer program allows scientists to design synthetic DNA segments that indicate, in real time, the state of cells. Reported by the Gargiulo lab in “Nature Communications”, it will be used to screen for anti-cancer or viral infections drugs,…
Some hereditary genetic defects cause an exaggerated immune response that can be fatal. Using the CRISPR-Cas9 gene-editing tool, such defects can be corrected, thus normalizing the immune response, as researchers led by Klaus Rajewsky from the Max…
Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have new findings on brain stiffness as a marker of neuroinflammation in multiple sclerosis to report. In this section, they answer questions about their research…
Erasmus Mundus joint master in Germany, France, and Slovenia
Cold, isolation, weightlessness: People face extreme conditions in places like Antarctica or space. Space medicine is the study of how humans adapt to these environments and how to…
Clinicians Recently Performed the 100,000th Procedure Implanting an ICD Equipped with DX Technology – the World’s Only Single-Lead ICD System Providing Direct Atrial Sensing
They offer hope for people who do not respond to conventional treatments or for whom there is no effective therapy yet available: advanced therapy medicinal products (ATMPs). The first of these novel medications, developed using genetic and cell…